Pancreatic Cancer Research

ResearcherCase Comprehensive Cancer CenterNo recent work listed

Mark W. Jackson

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9249-5623; OpenAlex author ID A5070436308; NIH RePORTER profile ID 9492815. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
1
Labs led
1
Collaborators
7
Papers, trials and grants by year

2014: 1 grant · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper

Papers 4

  1. Targeting Pancreatic Cancer Cell Plasticity: The Latest in Therapeutics. Last author DOI 10.3390/cancers10010014↗
  2. Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer. Last author DOI 10.1158/1541-7786.mcr-16-0337↗
  3. CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression. Co-author DOI 10.18632/oncotarget.14194↗
  4. Cellular Prion Protein Mediates Pancreatic Cancer Cell Survival and Invasion through Association with and Enhanced Signaling of Notch1. Co-author DOI 10.1016/j.ajpath.2016.07.010↗

Grants 1

  1. A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer R21CA178651↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jacob M. Smigiel · 2 shared papers, 2017–2018 · strength 0.25
  2. Shuiliang Yu · 2 shared papers, 2016–2017 · strength 0.12
  3. Lan Zhou · 2 shared papers, 2016–2017 · strength 0.12
  4. Wei Xin · 2 shared papers, 2016–2017 · strength 0.12
  5. Yiwei Wang · 2 shared papers, 2016–2017 · strength 0.12
  6. Ming Li · 1 shared paper, 2017 · strength 0.07
  7. Man‐Sun Sy · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.